Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88


HPV-associated Oropharyngeal Cancers--Are They Preventable?

Kreimer AR, Chaturvedi AK.

Cancer Prev Res (Phila). 2011 Sep;4(9):1346-9. doi: 10.1158/1940-6207.CAPR-11-0379.


US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.

Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT; HPV Typing of Cancers Workgroup..

J Natl Cancer Inst. 2015 Apr 29;107(6):djv086. doi: 10.1093/jnci/djv086.


Human papillomavirus: changing paradigms in oropharyngeal cancer.

Adelstein DJ, Rodriguez CP.

Curr Oncol Rep. 2010 Mar;12(2):115-20. doi: 10.1007/s11912-010-0084-5.


Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.

Bogaards JA, Wallinga J, Brakenhoff RH, Meijer CJ, Berkhof J.

BMJ. 2015 May 12;350:h2016. doi: 10.1136/bmj.h2016.


Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?

Isaranuwatchai W, Graham DM, Siu LL, Hoch JS.

Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):763-5. doi: 10.1586/14737167.2014.946012. Review.


Current status of human papillomavirus vaccination.

Brotherton JM, Ogilvie GS.

Curr Opin Oncol. 2015 Sep;27(5):399-404. doi: 10.1097/CCO.0000000000000211. Review.


A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.

Graham DM, Isaranuwatchai W, Habbous S, de Oliveira C, Liu G, Siu LL, Hoch JS.

Cancer. 2015 Jun 1;121(11):1785-92. doi: 10.1002/cncr.29111.


Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study.

St Guily JL, Jacquard AC, Prétet JL, Haesebaert J, Beby-Defaux A, Clavel C, Agius G, Birembaut P, Okaïs C, Léocmach Y, Soubeyrand B, Pradat P, Riethmuller D, Mougin C, Denis F.

J Clin Virol. 2011 Jun;51(2):100-4. doi: 10.1016/j.jcv.2011.03.003.


The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer.

Gooi Z, Chan JY, Fakhry C.

Laryngoscope. 2016 Apr;126(4):894-900. doi: 10.1002/lary.25767. Review.


Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.

Riethmuller D, Jacquard AC, Lacau St Guily J, Aubin F, Carcopino X, Pradat P, Dahlab A, Prétet JL.

BMC Public Health. 2015 May 2;15:453. doi: 10.1186/s12889-015-1779-1.


Human Papilloma Virus and Oropharyngeal Carcinoma - Lessons from History.

Vlantis AC.

Chin J Dent Res. 2016 Mar;19(1):9-16. doi: 10.3290/j.cjdr.a35692.


9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.

Pitisuttithum P, Velicer C, Luxembourg A.

Expert Rev Vaccines. 2015;14(11):1405-19. doi: 10.1586/14760584.2015.1089174. Review.


Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique.

Blumberg J, Monjane L, Prasad M, Carrilho C, Judson BL.

Cancer Epidemiol. 2015 Dec;39(6):1000-5. doi: 10.1016/j.canep.2015.10.015.


Low prevalence of human papillomavirus in oral cavity carcinomas.

Machado J, Reis PP, Zhang T, Simpson C, Xu W, Perez-Ordonez B, Goldstein DP, Brown DH, Gilbert RW, Gullane PJ, Irish JC, Kamel-Reid S.

Head Neck Oncol. 2010 Mar 12;2:6. doi: 10.1186/1758-3284-2-6.


Undifferentiated carcinoma of the oropharynx: a human papillomavirus-associated tumor with a favorable prognosis.

Carpenter DH, El-Mofty SK, Lewis JS Jr.

Mod Pathol. 2011 Oct;24(10):1306-12. doi: 10.1038/modpathol.2011.87.


Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers.

Hocking JS, Stein A, Conway EL, Regan D, Grulich A, Law M, Brotherton JM.

Br J Cancer. 2011 Mar 1;104(5):886-91. doi: 10.1038/sj.bjc.6606091.


Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.

Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ, Anderson RN, Yankey D, Edwards BK.

J Natl Cancer Inst. 2013 Feb 6;105(3):175-201. doi: 10.1093/jnci/djs491.


Prospects for prevention of HPV-driven oropharynx cancer.

Kreimer AR.

Oral Oncol. 2014 Jun;50(6):555-9. doi: 10.1016/j.oraloncology.2013.06.007.


Human papillomavirus and oral cancer: a primer for dental public health professionals.

Chattopadhyay A, Weatherspoon D, Pinto A.

Community Dent Health. 2015 Jun;32(2):117-28. Review.


Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernández L, Idris A, Sánchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJ, Meijer CJ, Viscidi R, Muñoz N, Franceschi S; IARC Multicenter Oral Cancer Study Group..

J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83.

Items per page

Supplemental Content

Support Center